Clinical, Academic and Industry Background

American Board of Psychiatry and NeurologyDonald Rauh, MD, Ph.D. is a Diplomate of the American Board of Psychiatry and Neurology. He is also Board Certified in both General Psychiatry and in Child & Adolescent Psychiatry.  An unusual combination of clinical, academic and industry experience has deepened his perspective on the treatment of behavioral and psychiatric problems in adults, children and adolescents.

Dr. Rauh is a graduate of Case Western Reserve University where he earned both an M.D. and a Ph.D. in Biomedical Engineering with a subspecialty in information processing in the central nervous system.

His interest in research took him first to Technicare, a subsidiary of Johnson and Johnson (JNJ). There he served as the Director of Technology Planning working on the development of advanced imaging equipment as well as novel contrast agents.  He then relocated to Pennsylvania to help in the start-up of a new company within JNJ.  There he served as the Director of Clinical Development. He: conducted Phase I, II and III multi-center Clinical Trials, and won the JNJ Achievement Award.

He returned to the practice of medicine with a Residency in psychiatry at the Institute of Pennsylvania Hospital where he received the Glencairn Award for Research. He was also named the Laughlin Fellow for Achievement, Dedication and Scholarship.  His work was recognized as well with The Patient Care Award. He then completed a Fellowship in Child & Adolescent Psychiatry at Thomas Jefferson University where he served as the Chief Fellow. In addition, he was named Resident of the Year by the Regional Council on Child and Adolescent Psychiatry.   He also received the Philadelphia Psychiatric Society’s Resident Research Award for his work on the Mechanisms of Action of Omega-3 Fatty Acids in Psychiatric Disorders.

While working through his Residency and Fellowship, he concurrently studied psychoanalysis through four years of academic work in Child and Adolescent Psychoanalysis and all five years of the Adult Psychoanalytic training program.  He continued his work in psychoanalysis as an advanced candidate and academic graduate.

Dr. Rauh believes strongly in treating the whole person, factoring in circumstances such as diet and exercise that affect total health.  When medication is indicated, he works incrementally. He begins with small doses and carefully studies the effect of each increment on both the patient and their symptoms.  Clinical research draws conclusions from a general population, but each patient responds differently to medications, supplements, and/or vitamins.  Dr. Rauh is committed to studying, analyzing and responding to those differences.

He has spent his professional life studying the central nervous system as an engineer, as a physician, and as a therapist.  The ability to see and interpret neurophysiological issues in all three of these dimensions is one of the strengths of his practice.

Professional Recognitions in Psychiatric Care

Dr. Rauh has received the following awards and recognitions in his field.

  • Glencarirn Award for Research
  • American Psychiatric Association Fellow – FAPA
  • Laughlin Fellow for Achievement, Dedication, and Scholarship
  • Patient Care Award
  • Nominated for American Psychoanalytic Association Fellowship
  • Philadelphia Psychiatric Society Resident Research Award – 1999
  • Regional Council on Child & Adolescent Psychiatry Resident of the Year – 2000
  • Johnson & Johnson Achievement Award

Additional Training:

  • Executive Leadership Training – Center for Creative Leadership
  • Shadow Work – Basic, Advanced, & Leader Facilitator Training

Memberships:

  • American Psychiatric Association
  • American Academy of Child & Adolescent Psychiatry
  • Philadelphia Psychiatric Society
  • Psychoanalytic Center of Philadelphia
  • Society for Psychoanalytic Psychology
  • Bucks County Medical Society
  • Lifetime Member of the American Medical Association
  • American Association for the Advancement of Science (AAAS)
  • Federation of American Scientists
  • National Alliance on Mental Illness